Eli Lilly, Centessa Pharmaceuticals receive US green light
MLex Summary: Eli Lilly's acquisition of Centessa Pharmaceuticals plc saw the applicable Hart-Scott-Rodino Act waiting period expire on May 21, giving the deal approval in the United States, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article